Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director, 10%+ Owner
-
Stock Symbol
-
JANX on Nasdaq
Ra Capital Management, L.P. - trading volume in the past year for Janux Therapeutics, Inc.
Holdings reported by Ra Capital Management, L.P. for Janux Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
9.32M |
$417M |
$44.75 |
Oct 18, 2024 |
Indirect |
|
|
| Pre-Funded Warrants (Right to Buy) |
1.4M |
$65M |
$46.50 |
Mar 4, 2024 |
Indirect |
Common Stock |
|
| Stock Option (Right to Buy) |
8.35K |
|
|
Jun 26, 2024 |
Indirect |
Common Stock |
|
Transactions reported by Ra Capital Management, L.P. for Janux Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.